Astria Therapeutics Inc (ATXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Operating Expenses | 21,681 | 18,119 | 0 | 0 |
| Operating Income | -21,681 | -18,119 | N/A | N/A |
| Interest Expense | 206 | 0 | 0 | 0 |
| Other Income | 3 | 1 | 0 | 0 |
| Pre-tax Income | -21,884 | -18,118 | 0 | 0 |
| Net Income Continuous | -21,884 | -18,118 | N/A | N/A |
| Net Income | $-21,884 | $-18,118 | $N/A | $N/A |
| EPS Basic Total Ops | -3,092.98 | -2,867.43 | N/A | N/A |
| EPS Basic Continuous Ops | -3,092.69 | -2,867.52 | N/A | N/A |
| EPS Diluted Total Ops | -3,092.98 | -2,867.43 | N/A | N/A |
| EPS Diluted Continuous Ops | -3,092.69 | -2,867.52 | N/A | N/A |
| EBITDA(a) | $-21,433 | $-17,799 | $N/A | $N/A |